U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Pulsatile drug delivery system

Patent 5229131 Issued on July 20, 1993. Estimated Expiration Date: Icon_subject October 7, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Primary delivery system comprising secondary dosage form
Patent #: 4773907
Issued on: 09/27/1988
Inventor: Urquhart ,   et al.

Constant release system with pulsed release
Patent #: 4777049
Issued on: 10/11/1988
Inventor: Magruder ,   et al.

Osmotic system comprising plurality of members for dispensing drug Patent #: 4783337
Issued on: 11/08/1988
Inventor: Wong ,   et al.

Inventors

Application

No. 771895 filed on 10/07/1991

US Classes:

424/451, Capsules (e.g., of gelatin, of chocolate, etc.)424/464, Tablets, lozenges, or pills424/473, With porous, perforated, apertured, or sieved layer (e.g., dialyzing layer, microporous layer, etc.)424/480Cellulose or derivative

Examiners

Primary: Page, Thurman K.
Assistant: Phelan, D. Gabrielle

Attorney, Agent or Firm

International Class

A61K 009/48

Abstract

A drug delivery system for administering a drug in controlled pulse doses to an aqueous environment in the body of a living being has one or more, and preferably less than ten, individual drug-containing subunits in a unitary drug depot, such as a tablet or capsule. The individual subunits are designed to dissolve at different sites and/or times in the gastrointestinal tract to release pulse doses of drug into the portal system in an analogous manner to the rate of release from an immediate release dosage form administered according to an appropriate dosing schedule. The dissolution time of the individual subunits can be controlled by several methods including the provision of pH-sensitive enteric coatings and permeability-controlled coatings. The drug delivery system has significant advantages for the oral administration of first-pass metabolized drugs which exhibit a non-linear relationship between input rate of the drug into the portal system and bioavailability.

PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$16.95more info
 
Sign InRegister
Username  
Password   
forgot password?